QLTY ETF Analysis: GMO U.S. Quality | NYSE
Large Blend | NYSE, USA | Market Cap: 5.194m USD | 12M Return: 18.2% | US90139K1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.6M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 2.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The GMO U.S. Quality ETF (QLTY) is an actively managed exchange-traded fund listed on the NYSE that invests primarily in equities of U.S. companies its adviser, Grantham, Mayo, Van Otterloo & Co. LLC (GMO), considers to be of high quality. The portfolio consists mainly of common and preferred stocks, with smaller permitted allocations to convertible securities, depositary receipts, equity REITs, income trusts, and other investment companies that invest primarily in equity securities.
As an actively managed product classified in the Large Blend ETF category, QLTY relies on GMOs fundamental research and quality-focused security selection rather than passive index replication, distinguishing it from the majority of ETFs in the U.S. equity space. The fund was launched in November 2023 and currently sits in the mid-cap market capitalization range.
- Quality factor lags as growth and value rebound
- Fund inflows surge amid flight to defensive equities
- Vanguard and BlackRock quality ETFs compress fee margins
As of October 05, 2026, the stock is trading at USD 43.15 with a total of 397,485 shares traded. Over the past week, the price has changed by -0.04%, over one month by +0.58%, over three months by +3.62% and over the past year by +18.23%.
Current recommended Stop Loss: 42.50 (which is 1.5% or 1.8 ATR below the current price).
GMO U.S. Quality has no consensus analysts rating.